Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TRAUMA-SALBE Mayrhofer
- Development stage
- Unknown
- Lead developer
- Kwizda
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
TRAUMA-SALBE Mayrhofer is an over-the-counter (OTC) topical ointment developed and marketed by Kwizda Pharma for the treatment of minor injuries, musculoskeletal pain, and trauma-related conditions. The product is available in two distinct formulations tailored to the stage of injury. The 'cooling' formulation is designed for acute injuries (first 48 hours), containing methyl salicylate, menthol, and camphor to provide pain relief through cold-induced vasoconstriction and anti-inflammatory action. The 'warming' formulation is intended for chronic conditions or later-stage recovery, containing methyl salicylate, purified turpentine oil, and cayenne pepper extract (standardized to capsaicinoids) to act as a rubefacient, promoting local blood circulation and relieving muscle tension. Both formulations provide local analgesic and anti-inflammatory effects for conditions such as sprains, strains, and contusions.
- Brand names
- TRAUMA-SALBE MayrhoferTRAUMA-SALBE Mayrhofer kühlendTRAUMA-SALBE Mayrhofer wärmend
- Other names
- Trauma-Salbe Mayrhofer
02
Targets
TRPV1 (Transient receptor potential cation channel subfamily V member 1)COX
Beyond the preview
Go deeper on TRAUMA-SALBE Mayrhofer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRAUMA-SALBE Mayrhofer.